Mirati Therapeutics
Earnings Date & Report
Last updated:
Mirati Therapeutics’s last earnings date was on 4 Nov 2024.
Mirati Therapeutics stock Earnings report, Estimates & History
| 2020-02-25 | -1.5 | -1.83 |
|---|---|---|
| 2020-05-07 | -1.65 | -2.02 |
| 2020-08-06 | -2.1 | -1.89 |
| 2020-11-04 | -2.04 | -1.96 |
| 2021-02-25 | -2.28 | -2.08 |
| 2021-05-06 | -2.13 | -2.67 |
| 2021-08-05 | -2.41 | -3.23 |
| 2021-11-08 | -2.87 | -1.55 |
| 2022-02-28 | -3.01 | -3.72 |
| 2022-05-04 | -3.37 | -3.4 |
| 2022-08-03 | -3.53 | -3.18 |
| 2022-11-08 | -3.46 | -3.09 |
| 2023-02-28 | -3.74 | -3.51 |
| 2023-05-09 | -3.47 | -3.18 |
| 2023-08-08 | -3.23 | -3.04 |
| 2023-11-06 | -2.92 | -2.49 |
| 2024-02-27 | -2.61 | -3.51 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Mirati Therapeutics stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 4 Nov 2024 | N/A | N/A | N/A | N/A | N/A | |
| 6 Aug 2024 | N/A | N/A | N/A | N/A | N/A | |
| 7 May 2024 | N/A | N/A | N/A | N/A | N/A | |
| 27 Feb 2024 | Missed | -$2.61 | -$3.51 | 23.01M | N/A | |
| 6 Nov 2023 | Beat | -$2.92 | -$2.49 | 25.41M | 16.4M | |
| 8 Aug 2023 | Beat | -$3.23 | -$3.04 | 13.51M | 13.69M | Earnings Call Transcript |
| 9 May 2023 | Beat | -$3.47 | -$3.18 | 4.78M | 7.16M | Earnings Call Transcript |
| 28 Feb 2023 | Beat | -$3.74 | -$3.51 | 2.27M | 934K | Earnings Call Transcript |
| 8 Nov 2022 | Beat | -$3.46 | -$3.09 | N/A | 5.43M | Earnings Call Transcript |
| 3 Aug 2022 | Beat | -$3.53 | -$3.18 | N/A | 5.36M | Earnings Call Transcript |
| 4 May 2022 | Missed | -$3.37 | -$3.4 | 727.28K | 709K | Earnings Call Transcript |
| 28 Feb 2022 | Missed | -$3.01 | -$3.72 | 1.41M | 299K | Earnings Call Transcript |
| 8 Nov 2021 | Beat | -$2.87 | -$1.55 | 13.28M | 71.79M | Earnings Call Transcript |
| 5 Aug 2021 | Missed | -$2.41 | -$3.23 | 6.62M | N/A | |
| 6 May 2021 | Missed | -$2.13 | -$2.67 | 140K | N/A | |
| 25 Feb 2021 | Beat | -$2.28 | -$2.08 | 270K | 1.70M | |
| 4 Nov 2020 | Beat | -$2.04 | -$1.96 | 11.48M | 11.42M | |
| 6 Aug 2020 | Beat | -$2.1 | -$1.89 | N/A | N/A | |
| 7 May 2020 | Missed | -$1.65 | -$2.02 | 219.41K | 267K | |
| 25 Feb 2020 | Missed | -$1.5 | -$1.83 | 413.90K | 526K | |
Mirati Therapeutics Earnings report FAQs
When is Mirati Therapeutics's next Earnings date?
The company has not set the next earnings date yet. The latest Mirati Therapeutics's earnings date was on 6 Nov 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.